Previous Close | 23.44 |
Open | 24.04 |
Bid | 0.00 x 1400 |
Ask | 0.00 x 1000 |
Day's Range | 24.04 - 26.97 |
52 Week Range | 21.25 - 96.88 |
Volume | |
Avg. Volume | 820,343 |
Market Cap | 1.386B |
Beta (5Y Monthly) | 0.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CareDx (CDNA) delivered earnings and revenue surprises of -225% and 1%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The number of organ transplants has continued to grow over the years. With such a backlog of transplants, patients and clinicians alike want to ensure the safety of their new transplanted organ. Thankfully, medical diagnostic company CareDx (NASDAQ: CDNA) is working to address this issue.